Главная › Острый миелоидный лейкоз › Иллинойс › Chicago
Клинические исследования Острый миелоидный лейкоз в городе Chicago, IL
26 исследований по теме Острый миелоидный лейкоз ищут участников в центрах в городе Chicago и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- и еще 1
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Набор участниковФаза 1
- University of Chicago Comprehensive Cancer Center, Chicago
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Набор участниковФаза 2
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Набор участниковФаза 3
- University of Chicago Medicine, Chicago
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Набор участниковФаза 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- и еще 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Набор участниковФаза 1
- Lurie Children's Hospital-Chicago, Chicago
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Набор участниковФаза 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Набор участниковФаза 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Набор участниковФаза 2
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Набор участниковФаза 3
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Набор участниковФаза 1/2
- The University of Chicago Medical Center, Chicago
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Набор участниковФаза 1/2
- University of Chicago, Chicago
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Набор участниковФаза 3
- Lurie Children's Hospital-Chicago, Chicago
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Набор участниковФаза 3
- US-Chigago IL-UHCHICAGO, Chicago
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Набор участниковФаза 1
- University of Chicago Comprehensive Cancer Center, Chicago
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Набор участниковФаза 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Набор участниковФаза 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
- Comer Children's Hospital, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Набор участниковФаза 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Набор участниковНаблюдательное исследование
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- и еще 2
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Набор участниковФаза 2
- University of Illinois Cancer Center, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Набор участниковФаза 1
- University of Chicago, Chicago
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Набор участниковФаза 1/2
- Northwestern University, Chicago
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Набор участниковФаза 1/2
- Northwestern, Chicago
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Набор участниковФаза 1
- Northwestern Medicine, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Набор участниковФаза 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Набор участниковФаза 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Исследования Острый миелоидный лейкоз в других городах
- Houston, TX85 исследований
- New York City, NY51 исследование
- Boston, MA44 исследований
- Baldwin Park, CA40 исследований
- Seattle, WA40 исследований
- Columbus, OH35 исследований
- Philadelphia, PA34 исследований
- Durham, NC33 исследований
- Atlanta, GA30 исследований
- Tampa, FL29 исследований
- Portland, OR25 исследований
- Miami, FL24 исследований
Другие исследования в городе Chicago
- Немелкоклеточный рак легкого61 исследование
- Рак молочной железы58 исследований
- Рак (все виды)51 исследование
- Метастатический рак45 исследований
- Рак простаты45 исследований
- Ожирение41 исследование
- Рак легких41 исследование
- Рак яичников36 исследований
- Инсульт34 исследований
- Колоректальный рак33 исследований
- Сердечная недостаточность31 исследование
- Избыточный вес28 исследований
Источник: ClinicalTrials.gov, данные получены 5 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.